May 30 |
Cibus’ White Mold (Sclerotinia) Resistance Trait Program Confirms Important Milestone for Next Generation Gene Edits in Canola
|
May 15 |
Canada Added to a Growing List of Countries Regulating Cibus’ Gene Editing Technologies Similar to Conventional Breeding
|
May 13 |
Cibus to Participate in the BMO Global Farm to Market Conference
|
May 12 |
Cibus, Inc. (CBUS) Q1 2024 Earnings Call Transcript
|
May 9 |
Cibus GAAP EPS of -$1.12 misses by $0.11, revenue of $0.54M beats by $0.14M
|
May 9 |
Cibus Reports First Quarter Financial Results and Provides Business Update
|
May 8 |
Cibus Q1 Earnings Preview
|
May 3 |
Cibus, Inc.'s (NASDAQ:CBUS) top owners are individual investors with 53% stake, while 26% is held by institutions
|
Apr 25 |
Cibus to Report First Quarter 2024 Financial Results on May 9, 2024 and Host Conference Call
|
Mar 23 |
Cibus Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags
|